Joseph P. Hagan - Chief Executive Officer, Director at Regulus Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
RGLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Joseph P. Hagan - trading volume in the past year for Regulus Therapeutics Inc.

Holdings reported by Joseph P. Hagan for Regulus Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 57,112 $68 K $1.19 Jan 18, 2024 Direct
Stock Option (Right to Buy) 990,000 May 20, 2024 Direct Common Stock

Transactions reported by Joseph P. Hagan for Regulus Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership